Groundbreaking study unveils new insights into neurodegenerative disorder symptoms

FHS
March 14, 2024
11:26 am

Identification of clinical disease trajectories in neurodegenerative disorders with natural language processing.

There’s a less intimidating alternative to EpiPens for dangerous allergic reactions. Why won’t the FDA approve it?

My son Thomas has carried around a needle since he entered kindergarten at the age of 5. That was a big responsibility for a small

December 29, 2023

FDA approves Luye Pharma’s ERZOFRI for schizophrenia

Schizophrenia and schizoaffective disorder are severe, chronic psychiatric conditions that often result in relapses. Credit: Doidam 10 / Shutterstock. The US Food and Drug Administration

July 29, 2024

AbbVie and Tentarix enter biologic development deal

Share this article The alliance will leverage AbbVie’s capabilities in oncology and immunology. Credit: AbbVie. AbbVie has signed a strategic partnership agreement with Tentarix Biotherapeutics

February 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.